Back
Gilead Sciences, Inc. Vs. AbbVie, Inc. Industry Stock Comparison
Sell
45
GILD
Gilead Sciences, Inc.
Last Price:
$121.57
Seasonality Move:
3.86%
Sell
50
ABBV
AbbVie, Inc.
Last Price:
$229.28
Seasonality Move:
2.16%
Sell
45
Gilead Sciences, Inc. (GILD)
is a Sell
Is Gilead Sciences, Inc. a Buy, Sell or Hold?
-
The current Gilead Sciences, Inc. [GILD] share price is $121.60. The Score for GILD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
GILD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
AbbVie, Inc. (ABBV)
is a Sell
Is AbbVie, Inc. a Buy, Sell or Hold?
-
The current AbbVie, Inc. [ABBV] share price is $229.31. The Score for ABBV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GILD Stock Price Chart
What is Gilead Sciences, Inc.'s stock price today?
-
The Gilead Sciences, Inc. share price today is $121.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GILD is experiencing slight selling pressure.
ABBV Stock Price Chart
What is AbbVie, Inc.'s stock price today?
-
The AbbVie, Inc. share price today is $229.31Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing slight buying pressure.
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 45.72 | Sell |
| Chaikin Money Flow: | -1894693 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.75 - 125.15) | Sell |
| Bollinger Bands (100): | (114.43 - 123.85) | Buy |
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 53.89 | Buy |
| Chaikin Money Flow: | 1439571 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (224.15 - 229.33) | Buy |
| Bollinger Bands (100): | (213.73 - 231.91) | Buy |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 124.02 | Sell |
| 20-day SMA: | 122.36 | Sell |
| 50-day SMA: | 122.79 | Sell |
| 200-day SMA: | 113.76 | Buy |
| 8-day EMA: | 123.17 | Sell |
| 20-day EMA: | 123.08 | Sell |
| 50-day EMA: | 122.01 | Sell |
| 200-day EMA: | 113.57 | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 229.37 | Sell |
| 20-day SMA: | 226.67 | Buy |
| 50-day SMA: | 226.66 | Buy |
| 200-day SMA: | 206.14 | Buy |
| 8-day EMA: | 228.82 | Buy |
| 20-day EMA: | 227.79 | Buy |
| 50-day EMA: | 226.16 | Buy |
| 200-day EMA: | 210.81 | Buy |
Gilead Sciences, Inc. Earnings Growth & GILD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.57 per share.
AbbVie, Inc. Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.61 per share, and an increase next year of $1.59 per share.
Gilead Sciences, Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AbbVie, Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||